ABSTRACT Treating post-traumatic stress disorder (PTSD) related to military sexual trauma (MST) continues to be a priority in veteran populations. Because negative cognitions (NCs) contribute to PTSD severity and treatment, further understanding of how PTSD and related NCs can be addressed and changed within an MST sample is important. Our study analyzed 45 participants who received either cognitive processing therapy (n = 32) or present centered therapy (n = 13). Participants who received cognitive processing therapy had significantly lower NCs scores post-treatment and at follow-up sessions than participants in the present centered therapy condition ( p 0.05). In addition, NCs were positively correlated with PTSD severity ( p 0.05). Implications for future research are discussed for both MST-related and non-MST-related PTSD.
INTRODUCTION

Military sexual trauma (MST) is defined by the Department of Veteran Affairs
1 as "sexual harassment that is threatening in character or physical assault of a sexual nature that occurred while the victim was in the military, regardless of geographic location of the trauma, gender of the victim, or the relationship of the perpetrator." It is important to note that MST is not a clinical diagnosis, but rather, it is a traumatic event of a sexual nature that occurs while a person is on active duty, that often results in post-traumatic stress disorder (PTSD). 2 Moreover, because of the prevalence of and negative consequences of MST 3 in both returning military personnel and veterans, research related to clinical treatment of MSTrelated PTSD is critical.
Specifically, MST-related PTSD has been shown to have numerous negative health associations including comorbid psychiatric disorders (e.g., depression and substance use disorders), cardiovascular health problems, and socioeconomic difficulties (for a complete review see Surís et al 3 ). As such, treatment of MST-related PTSD continues to be a priority in clinical treatment settings including Veteran Affairs Medical Centers (VAMCs).
One of the most commonly utilized treatments for PTSD at both VAMCs and non-VAMCs is cognitive processing therapy (CPT). CPT is an evidence-based treatment (EBT) that has been found to be significantly more effective at treating PTSD than other forms of psychotherapy and pharmacotherapy. 4 CPT is a form of cognitive behavioral therapy that was originally developed for civilian survivors of rape 5 that has been adapted by the Veterans Health Administration to treat MST and combat-related PTSD. 6, 7 CPT effectively treats PTSD by having the patient recognize cognitive "stuck points," which are negative/distorted cognitions related to the patient's trauma(s). Over the course of CPT treatment, the therapist teaches the patient how to challenge negative cognitions (NCs). The patient learns how irrational interpretations of the traumatic experience maintain PTSD symptoms and negatively affects beliefs about self and the world. Through cognitive restructuring, reductions in PTSD symptoms will occur. 4 NCs may inhibit a patient's ability to fully engage in the treatment process. Furthermore, higher levels of NC's are associated with greater severity of PTSD symptoms. [8] [9] [10] [11] [12] Since its development, CPT has demonstrated effectiveness in multiple populations, including survivors of MST. 13 Despite the wide breadth of knowledge regarding CPT's efficacy in treating PTSD, 4, 6, 7, [13] [14] [15] [16] a review of the literature revealed only one published study which examined the effects of CPT on reducing the number of NCs. 17 These researchers reported that CPT was effective at reducing NCs in a sample of high school students who had experienced a traumatic event. 17 To date, no published studies have examined the effects of CPT on NCs in patients diagnosed with PTSD or in survivors of MST.
Several critical issues were investigated in this study; we examined the relationship between NCs and symptom severity among veterans diagnosed with PTSD related to MST and assessed the effects of two interventions on clinical outcomes in this population. We had three hypotheses: (1) Veterans treated with CPT would demonstrate a greater reduction in NCs compared to those treated with a nontrauma-focused treatment (Present-centered therapy, PCT); (2) treatment with CPT would result in sustained symptom reduction over the pre-and post-treatment (PT) evaluations; and (3) the number of reported NCs would be positively correlated with measures of symptom severity among Veterans diagnosed with PTSD related to MST.
METHOD
Participants
The study was conducted at a large Southwestern VAMC. Participants were recruited via posted advertisements, recruitment letters, and clinician referral. Participants received monetary compensation for their participation. Inclusion criteria were as follows: (1) veteran status with a diagnosis of MST-related PTSD, (2) MST occurrence at least 3 months prior, (3) MST identified as the most distressing PTSD-related trauma, (4) at least one clear memory of the MST, and (5) no changes to psychiatric medication in the past 6 weeks. Exclusion criteria were as follows: (1) substance dependence/abuse in the past 3 months, (2) current psychotic symptoms, (3) unstable bipolar disorder, (4) severe cognitive impairment, (5) concurrent enrollment in an EBT for PTSD, (6) involvement in a violent intimate partner relationship, and/or (7) significant suicidal/homicidal ideation. The study was approved by the Institutional Review Board of the Veteran Affairs North Texas Health Care System, and all participants gave their written consent before taking part in the study.
One-hundred twenty-one participants were randomized to receive either CPT or PCT. Four masters or doctoral level female therapists (therapist A, B, C, and D) provided therapy to study participants. Two doctoral-level therapists administered the study measures and were blinded to the patient's therapy condition. Before analyzing data, therapist fidelity was assessed for both conditions. 18 To ensure accurate administration of the manualized therapies, a random selection of session videos from each therapist was rated by an independent reviewer from 1 (poor) to 7 (excellent). As previously discussed (see Surís et al Because the accuracy of psychotherapeutic administration is strongly related to the effectiveness of EBTs, [19] [20] [21] it was decided that only the data from therapists with average fidelity ratings of 5 (good) or better would be included in data analyses. Therefore, therapists C and D's data were excluded, leaving 45 participants (n = 32 for CPT and n = 13 for PCT).
Measures
The Post-traumatic Cognitions Inventory (PTCI) 22 was used to assess for trauma-related NCs. The PTCI is a self-report instrument with 36 items that assess how much the participant agrees with each statement from 1 (totally disagree) to 7 (totally agree). The PTCI generates a general NCs score as well as scores on three subscales: (1) NCs about self, (2) NCs about the world, and (3) NCs about self-blame. The PTCI has good internal consistency (PTCI total score, Cronbach's a = 0.97; NCs about self, Cronbach's a = 0.97; NCs about the world, Cronbach's a = 0.88; self-blame, Cronbach's a = 0.86) and test-retest reliability (PTCI total score, p = 0.74; NCs about self, p = 0.75; NCs about the world, p = 0.89; selfblame, p = 0.89). 22 The PTCI subscales also have strong convergent validity with similar NC measures on the Personal Beliefs and Reactions Scale (PBRS). 22, 23 For example, the NCs about self subscale was significantly related to the self-scale of the PBRS ( p = 0.085), the NCs about the world subscale was significantly related to the others ( p = 0.64) and safety ( p = 0.65) scales of the PBRS, and the selfblame subscale was significantly related to the self-blame ( p = 0.50) scale of the PBRS. 22 The PTSD Checklist-Military (PCL-M) 24 was used to assess for PTSD severity. The PCL-M is a self-report measure that is commonly utilized to assess a patient's PTSD symptom severity over the course of treatment. The PCL-M is a 17-item self-report measure of PTSD symptom severity, with each item scored from 1 (Not at all) to 5 (Extremely). The PCL-M has strong test-retest reliability (r = 0.96) 25 and concurrent validity to measures of PTSD including the Mississippi Scale for Combat PTSD (r = 0.93) 25, 26 and the Clinician Administered PTSD Scale (CAPS; r = 0.93). 25, 27 The CAPS is clinician administered instrument that is one of the "gold-standard" measures used to diagnose PTSD as well as to measure PTSD symptom severity. 27, 28 The CAPS is a 30-item semi-structured interview used to assess the frequency and intensity of PTSD symptoms. The CAPS has strong inter-rater reliability (k = 0.95-1.00) and strong concurrent validity to other measures of PTSD including the PCL-M (r = 0.93) and Mississippi Scale for Combat-related PTSD (r = 0.70, r = 0.81). 27, 28 Although the PCL-M and the CAPS correlate highly, we administered both measures because patients sometimes differ in their level of disclosure during self-report compared to clinician administered interviews. 29 This method ensures that both patient and clinician perceptions of PTSD symptoms are assessed. In addition, measurement of PTSD severity with both the PCL-M and the CAPS is commonly utilized in clinical PTSD research (see Surís et al 13 
Procedure
Following informed consent, participants underwent a baseline assessment that included administration of the PTCI, CAPS, PCL-M, and a demographics form. Participants then received 12 weekly 1-hour sessions of either CPT or PCT (a comparison condition that did not address NCs and instead focused on general support and psychoeducation 31 ). After psychotherapy completion, participants were readministered the PTCI, CAPS, and PCL-M 4 subsequent times (1 week, 2 months, 4 months, and 6 months PT).
DATA ANALYSES
Statistical analyses were conducted using SPSS, version 19.
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Baseline characteristics were compared via independent sample t tests for continuous measures (e.g., age and education) and c 2 analyses for qualitative measures (e.g., gender, ethnicity, and attrition). To examine treatment efficacy, a 2 (treatment) + 5 (assessment session) repeated measure ANOVA was calculated on scores from the PTCI (total score and subscale scores). Post hoc independent sample t tests were used to assess for any differences between the treatment conditions at specific time points. Within-condition PTCI differences over the course of treatment were tested via dependent sample t tests. To determine if the number of NCs was associated with the PTSD symptom severity, a Pearson's correlation was calculated.
RESULTS
At baseline, there were no significant differences between treatment condition for any demographic variables except for age and education (see Table I ). No significant differences were found between the two treatment conditions on the PTCI total score or on any of the subscale scores at the baseline evaluation (see Table II ). There were also no significant baseline differences between the two groups on measures of PTSD severity (CAPS and PCL-M total Score). No significant differences were found based on gender or ethnicity for CAPS, PCL-M, PTCI total score, or PTCI subscale scores at any session. However, participants in the CPT condition were significantly younger and more educated than participants in the PCT condition. Because the two treatment groups differed significantly in age and educational level, both variables were used as covariates when examining treatment effects. The repeated -measure ANCOVA revealed that neither variable had any effect on the PCTI total or subscale scores. No significant differences were found for PTCI scores or its subscales between participants who withdrew from or completed the study. In addition, a c 2 analysis revealed that there was no differential withdrawal between the two treatment conditions, c 2 (1, N = 45) = 1.19, p = 0.275.
PTCI Total Score
A repeated measure ANCOVA of the PTCI total score revealed a significant main effect of treatment condition, F(1,25) = 6.40, p = 0.018, partial m 2 = 0.20. Results indicated that participants in the CPT condition showed greater reductions of their PTCI total score compared to participants in the PCT condition. However, there was no main effect of time, F(4,22) = 0.67, p = 0.62, partial m 2 = 0.11, and no significant interaction between treatment condition and time, F(4,22) = 1.17, p = 0.35, partial m 2 = 0.18. Follow-up t tests (see Table II ) revealed that participants in the CPT condition had significantly lower scores at 1 week, 2 months, 4 months, and 6 months PT compared to the PCT condition. In addition, participants in the CPT condition showed significant withincondition decreases from baseline to 6 months PT, while participants in the PCT condition did not. (Table II) revealed that participants in the CPT condition had significantly lower scores at 1 week, 2 months, 4 months, and 6 months PT compared to participants in the PCT condition. In addition, participants in the CPT condition showed significant withincondition decreases from baseline to 6 months PT, while participants in the PCT condition did not. (Table II) revealed that participants in the CPT condition had significantly lower scores at 1 week and 4 months PT, and nonsignificant trends at 2 months and 6 months when compared to participants in the PCT condition. In addition, participants in the CPT condition showed significant within-condition decreases from baseline to 6 months PT, while participants in the PCT condition did not. (Table II) revealed a nonsignificant trend with participants in the CPT condition reporting lower scores than participants in the PCT condition at 2 months. In addition, participants in the CPT condition showed significant within-condition decreases from baseline to 6 months PT, while participants in the PCT condition did not.
NCs About Self
NCs About the World
Self-Blame
NCs and PTSD Statistically significant relationships were found between the PTSD severity measures (PCL-M and CAPS) and PTCI total score, NCs about self, and NCs about the world at all assessment sessions (Table III) . In addition, statistically significant relationships were found between self-blame and the PTSD severity measures at 1 week (CAPS only), 2 months, and 6 months PT, but not at baseline or 4 months PT.
DISCUSSION
This study is the first to provide data on the effectiveness of CPT in reducing NCs in Veterans with MST-related PTSD.
Regarding the first hypothesis, we found that CPT was significantly more effective at reducing a participant's general NCs, NCs about one's self, and NCs about the world when compared to PCT. Trends toward significantly greater reductions in self-blame were also observed within participants in the CPT condition in comparison to participants in the PCT condition. For the second hypothesis, we found that CPT was effective at significantly reducing NCs pre-post treatment, with significant reductions between baseline NCs and all sessions PT found. This finding was not replicated in the PCT condition. In addition to demonstrating the overall superiority of CPT in decreasing NCs associated with PTSD in an MST sample, our results also supported our third hypothesis that NC's would be positively correlated with PTSD severity. Consistent with previous studies, [8] [9] [10] [11] [12] we found strong positive correlations between NCs (total score, NC-self, NCworld) and PTSD severity (as measured by the PCL-M and CAPS). In addition, significant positive correlations were found between the self-blame subscale and PTSD severity at three of the five sessions. These results are consistent with previous studies on the effects of NCs. 9 Furthermore, they highlight the need to address NCs in Veterans with PTSD related to MST.
The results from these analyses should be interpreted carefully, given the exclusion of a large portion of the study sample because of poor therapist fidelity. As a result, the data from participants under the two therapist's care were excluded from the analyses. As a consequence, the results from this study should be replicated before any firm conclusions can be made about treatment outcomes, although the statistical analyses completed indicate that CPT is superior to PCT in reducing NCs in this sample of Veterans with MSTrelated PTSD. Furthermore, the correlational analyses suggest that a higher number of NCs are associated with greater severity of PTSD.
MST-related PTSD can be a challenging disorder to effectively treat. As demonstrated by Suris et al, 13 although CPT is effective, when compared with outcomes in other populations with PTSD, Veterans with MST did not improve as quickly as other populations with PTSD who engage in CPT. Veterans with MST appear to resemble those described by Galovski et al, 33 who characterized patients who are slower to improve as "partial responders" and determined that they are likely to require additional sessions to attain optimal benefit. Despite the noted methodological limitations in our study, it appears that 12 sessions of CPT can successfully reduce the severity of NC's in Veterans with PTSD related to MST. Further research is necessary to determine if 12 sessions is optimal in reducing NCs, or if additional sessions would provide further reduction and benefit.
